NO20060376L - Fremgangsmater for fremstilling av 1-[(benzotmidazol-l-yl)quinolm-8-yl]piperidin-4-ylamin-derivater - Google Patents

Fremgangsmater for fremstilling av 1-[(benzotmidazol-l-yl)quinolm-8-yl]piperidin-4-ylamin-derivater

Info

Publication number
NO20060376L
NO20060376L NO20060376A NO20060376A NO20060376L NO 20060376 L NO20060376 L NO 20060376L NO 20060376 A NO20060376 A NO 20060376A NO 20060376 A NO20060376 A NO 20060376A NO 20060376 L NO20060376 L NO 20060376L
Authority
NO
Norway
Prior art keywords
preparation
benzothmidazol
quinol
piperidin
methods
Prior art date
Application number
NO20060376A
Other languages
English (en)
Norwegian (no)
Inventor
Norma Jacqueline Tom
Michael James Castaldi
David Harold Brown Ripin
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of NO20060376L publication Critical patent/NO20060376L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Epoxy Compounds (AREA)
NO20060376A 2003-06-24 2006-01-24 Fremgangsmater for fremstilling av 1-[(benzotmidazol-l-yl)quinolm-8-yl]piperidin-4-ylamin-derivater NO20060376L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48217603P 2003-06-24 2003-06-24
PCT/IB2004/001983 WO2004113322A1 (en) 2003-06-24 2004-06-14 Processes for the preparation of 1-[(benzoimidazole-1yl) quinolin-8-yl] piperidin-4-ylamine derivatives

Publications (1)

Publication Number Publication Date
NO20060376L true NO20060376L (no) 2006-01-24

Family

ID=33539339

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20060376A NO20060376L (no) 2003-06-24 2006-01-24 Fremgangsmater for fremstilling av 1-[(benzotmidazol-l-yl)quinolm-8-yl]piperidin-4-ylamin-derivater

Country Status (24)

Country Link
US (2) US7183414B2 (de)
EP (1) EP1641780B1 (de)
JP (1) JP2007516168A (de)
KR (2) KR20070092333A (de)
CN (1) CN100404530C (de)
AR (1) AR044849A1 (de)
AT (1) ATE414077T1 (de)
AU (1) AU2004249511B2 (de)
BR (1) BRPI0411794A (de)
CA (1) CA2529032C (de)
CL (1) CL2004001470A1 (de)
CO (1) CO5650165A2 (de)
DE (1) DE602004017731D1 (de)
DK (1) DK1641780T3 (de)
ES (1) ES2315663T3 (de)
IL (1) IL172064A (de)
MX (1) MXPA05014203A (de)
NO (1) NO20060376L (de)
NZ (2) NZ543714A (de)
RU (1) RU2323214C2 (de)
SG (1) SG161745A1 (de)
TW (1) TWI294425B (de)
WO (1) WO2004113322A1 (de)
ZA (1) ZA200509253B (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0411421D0 (en) * 2004-05-21 2004-06-23 Glaxo Group Ltd Novel compounds
CA2582479C (en) * 2004-10-07 2011-07-12 Pfizer Products Inc. Benzoimidazole derivatives useful as antiproliferative agents
BRPI0610514A2 (pt) * 2005-04-05 2016-11-16 Pharmacopeia Inc composto, composição farmacêutica, e, método de tratamento de um distúrbio
US7504513B2 (en) 2006-02-27 2009-03-17 Hoffman-La Roche Inc. Thiazolyl-benzimidazoles
JP5576370B2 (ja) 2008-08-06 2014-08-20 ファイザー・インク Ｃｈｋ−１阻害剤としての６置換２−ヘテロシクリルアミノピラジン化合物
JP2012512223A (ja) 2008-12-18 2012-05-31 エフ．ホフマン−ラ ロシュ アーゲー チアゾリル−ベンズイミダゾール類
CN101993416B (zh) * 2009-08-27 2013-09-11 中国科学院上海药物研究所 喹啉类化合物、其制备方法、包含该化合物的药物组合物及该化合物的用途
JP6407504B2 (ja) 2012-09-21 2018-10-17 アログ・ファーマシューティカルズ・インコーポレイテッドＡｒｏｇ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ，Ｉｎｃ． 恒常的に活性であるリン酸化型ｆｌｔ３キナーゼの阻害方法
US10835525B2 (en) 2012-09-26 2020-11-17 Arog Pharmaceuticals, Inc. Method of inhibiting mutant C-KIT
US11642340B2 (en) 2012-09-26 2023-05-09 Arog Pharmaceuticals, Inc. Method of inhibiting mutant C-KIT
TWI599356B (zh) 2012-09-26 2017-09-21 安羅格製藥有限責任公司 抑制突變型ｃ－ｋｉｔ的方法
BR112015016282A2 (en) 2013-01-07 2017-07-11 Arog Pharmaceuticals, Inc. crenolanib for treatment of mutated flt3 proliferative disorders
US10463658B2 (en) 2013-10-25 2019-11-05 Videra Pharmaceuticals, Llc Method of inhibiting FLT3 kinase
US12534764B2 (en) 2016-11-02 2026-01-27 Arog Pharmaceuticals, Inc. Crenolanib for treating FLT3 mutated proliferative disorders associated mutations
US12662706B2 (en) 2016-11-02 2026-06-23 Arog Pharmaceuticals, Inc. Crenolanib for treating FLT3 mutated proliferative disorders associated mutations
KR20180074792A (ko) 2016-11-02 2018-07-03 아로그 파마슈티칼스, 인코퍼레이티드 돌연변이 연관된 flt3 돌연변이된 증식성 장애를 치료하기 위한 크레노라닙
CN107382984B (zh) * 2017-08-24 2020-07-10 扬州市三药制药有限公司 一种治疗白血病药物的制备方法
CN107382983B (zh) * 2017-08-24 2020-08-07 扬州市三药制药有限公司 一种治疗白血病药物的合成方法
CN110840893A (zh) 2018-12-13 2020-02-28 安罗格制药有限责任公司 含克莱拉尼的药物组合物及其用途
CN109678849A (zh) * 2019-01-16 2019-04-26 北京悦康科创医药科技股份有限公司 一种抗癌药物的制备方法
US11471451B2 (en) 2019-08-19 2022-10-18 Arog Pharmaceuticals, Inc. Uses of crenolanib
CN117447376B (zh) * 2019-12-09 2026-06-09 苏州恩华生物医药科技有限公司 连双环结构sigma-1受体抑制剂
CN114981298B (zh) 2019-12-12 2024-08-20 听治疗有限责任公司 用于预防和治疗听力损失的组合物和方法
WO2022019998A1 (en) 2020-07-20 2022-01-27 Arog Pharmaceuticals, Inc. Crystal forms of crenolanib and methods of use thereof
AU2021320860A1 (en) 2020-08-05 2023-02-23 The General Hospital Corporation Salt inducible kinase inhibitors
US20220079934A1 (en) * 2020-09-17 2022-03-17 Arog Pharmaceuticals, Inc. Crenolanib for treating pain
US11524006B2 (en) 2020-09-17 2022-12-13 Arog Pharmaceuticals, Inc. Crenolanib for treating TRK kinase associated proliferative disorders
WO2022090547A1 (en) 2020-10-30 2022-05-05 Dsm Ip Assets B.V. Production of carotenoids by fermentation
US11969420B2 (en) 2020-10-30 2024-04-30 Arog Pharmaceuticals, Inc. Combination therapy of crenolanib and apoptosis pathway agents for the treatment of proliferative disorders
CN113683594B (zh) * 2021-09-07 2022-12-27 曲靖师范学院 一种喹啉-苯并咪唑盐类化合物及其合成方法和应用
JP2023063189A (ja) 2021-10-22 2023-05-09 アログ・ファーマシューティカルズ・インコーポレイテッド 以前の治療に対して再発性／不応性のｆｌｔ３突然変異増殖性障害を治療するためのクレノラニブ

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4897401A (en) * 1987-06-19 1990-01-30 Janssen Pharmaceutical N.V. N-(4-piperidinyl) bicyclic condensed 2-imidazolamine derivatives useful in treating allergic diseases
US5478832A (en) * 1992-05-08 1995-12-26 The Green Cross Corporation Quinoline compounds
WO1998038156A1 (en) * 1997-02-27 1998-09-03 Takeda Chemical Industries, Ltd. Amine compounds, their production and use as amyloid-beta production inhibitors
UA75055C2 (uk) * 1999-11-30 2006-03-15 Пфайзер Продактс Інк. Похідні бензоімідазолу, що використовуються як антипроліферативний засіб, фармацевтична композиція на їх основі
JP4554135B2 (ja) * 1999-12-10 2010-09-29 富士フイルム株式会社 インクジェットヘッドおよび印刷装置
US6515179B2 (en) * 2000-09-14 2003-02-04 Kaneka Corporation Process for the removal of nitrobenzenesulfonyl
PA8580301A1 (es) * 2002-08-28 2005-05-24 Pfizer Prod Inc Nuevos derivados de benzoimidazol utiles como agentes antiproliferativos

Also Published As

Publication number Publication date
BRPI0411794A (pt) 2006-08-08
KR20060012033A (ko) 2006-02-06
CA2529032A1 (en) 2004-12-29
AU2004249511B2 (en) 2011-01-20
IL172064A (en) 2011-01-31
HK1089170A1 (en) 2006-11-24
NZ543714A (en) 2009-06-26
AU2004249511A1 (en) 2004-12-29
RU2323214C2 (ru) 2008-04-27
DK1641780T3 (da) 2009-02-02
ZA200509253B (en) 2007-01-31
KR20070092333A (ko) 2007-09-12
CO5650165A2 (es) 2006-06-30
ES2315663T3 (es) 2009-04-01
RU2005138367A (ru) 2006-08-10
SG161745A1 (en) 2010-06-29
CN1809556A (zh) 2006-07-26
CN100404530C (zh) 2008-07-23
EP1641780A1 (de) 2006-04-05
AR044849A1 (es) 2005-10-05
DE602004017731D1 (de) 2008-12-24
MXPA05014203A (es) 2006-02-24
CA2529032C (en) 2009-12-22
WO2004113322A1 (en) 2004-12-29
US20070088032A1 (en) 2007-04-19
TW200517393A (en) 2005-06-01
NZ571898A (en) 2010-01-29
CL2004001470A1 (es) 2005-05-13
TWI294425B (en) 2008-03-11
ATE414077T1 (de) 2008-11-15
US7183414B2 (en) 2007-02-27
KR100787649B1 (ko) 2007-12-21
EP1641780B1 (de) 2008-11-12
US20050020625A1 (en) 2005-01-27
JP2007516168A (ja) 2007-06-21

Similar Documents

Publication Publication Date Title
MXPA05014203A (es) Procedimientos para la preparacion de derivados de benzoimidazol.
NO20052802L (no) Pyrrolopyrimidinderivativer
NO20050099L (no) 2-ureido-6-heteroaryl-3H-benzoimidazol-4-karboksylsyrederivater og relaterte forbindelser sa som gyrase- og/eller topoisomerase IV-inhibitorer for behandling av bakterielle infeksjoner
NO20082338L (no) Pyrimidinderivater for behandling av avvikende cellevekst
WO2001064639A3 (en) Pde iv inhibiting amides, compositions and pharmaceutical use
NO20063382L (no) Nye kinolinderivater
NO20044501L (no) [1,4] diazenino [6,7,1-IJ] kinolin-derivater som antipsykotis og antifedme-midler
NO20071320L (no) Pyrazolsubstituerte aminoheteroarylforbindelser som protein kinase inhibitorer.
JO2282B1 (en) Oxazole derivatives
NO992524L (no) Konsenserte bicykliske pyrimidin-derivater
MXPA06013164A (es) Derivados de pirimidina para el tratamiento de crecimiento de celulas anormal.
TW200640900A (en) 1-(2h)-isoquinolone derivative
NO20092033L (no) Nye forbindelser
BR0310106A (pt) Composto, processo para a produção de um composto, composição farmacêutica, uso do composto e método para o tratamento de um sujeito em sofrimento de uma condição ou doença patalógica
NO20073140L (no) Pyrrolopyraziner og pyralopyraziner som er nyttige som inhibitorer av proteinkinaser
NO20051010L (no) Triazolderivater som transformerende vekst faktor (TGF) inhibitorer
ATE349432T1 (de) 2-anilino-pyrimidin-derivate als cyclin-abhängige kinase hemmer
NO982950L (no) Fenyltiazolderivater med inti-herpesvirus-egenskaper
NO20041631L (no) Piperazinderivater med CCR1 reseptor antagonist
WO2003084938A3 (en) Pyrimidone derivatives useful for the treatment of inflammatin and immunological diseases
GB0112348D0 (en) Compounds
NO20055565L (no) Anvendelse av derivater av 2,4-dihydro-[1,2,4]triazol-3-thion som inhibitorer av enzymet myeloperoksidase (MPO)
NO20055143L (no) Doseringsformer innbefattende AG013736
NO20050666L (no) 2,7-substituerte indoler og deres anvendelse som 5-HT6 modulatorer
NO20051900L (no) Kinazolinderivater som SRC tyrosin kinase inhibitorer

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application